http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1885342-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97bfe42c8a154a8a16b67823210f7e89 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| filingDate | 2006-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb9101370865de79fb7a3ecefe2e2278 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dc81a1a793676be7910de2b03080f35 |
| publicationDate | 2008-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1885342-A1 |
| titleOfInvention | Crystallization inhibitor and its use in gelatin capsules |
| abstract | The present invention describes soft gelatin capsules that encapsulate a water-insoluble active ingredient and an excipient composed of a crystallization inhibitor that stabilizes the water-insoluble inhibitor. The crystallization inhibitor being at least one mononacylglycerol compound whose acyl group is a fatty acid residue of 6-18 carbon atoms. The capsule contents are more resistant to turbidity, forming a coarse emulsion, and crystallization of the active ingredient compared with compositions absent the crystallization inhibitor. |
| priorityDate | 2005-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 84.